Drug intelligence / Profile preview

anti-TCR antibody

Development stage
Unknown
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous
01

Overview

An anti-TCR antibody is a monoclonal antibody designed to target the T-cell receptor (TCR) complex on T lymphocytes. By binding to the TCR, these antibodies can modulate T-cell activation, induce T-cell depletion, or downregulate the TCR/CD3 complex to suppress unwanted immune responses. In preclinical and clinical settings, anti-TCR antibodies are investigated for their immunomodulatory potential in autoimmune diseases, such as type 1 diabetes, and as induction therapy to prevent graft rejection in organ transplantation. They are also being explored as targeting moieties in antibody-drug conjugates (ADCs) and bispecific T-cell engagers (TCEs) for T-cell malignancies.

Other names
anti-T-cell receptor antibodyanti-TCR monoclonal antibody
02

Targets

CD247 (T-cell surface glycoprotein CD3 epsilon chain)NeuraminidaseFcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)LAT (Linker for activation of T cells)ZAP70 (Zeta-chain-associated protein kinase 70)γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on anti-TCR antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-TCR antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call